Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 8Thoracic 2Genitourinary 2NET 1Head & Neck 1Endocrine 1CNS 1Breast 1

Conditions

Lung Neoplasms 29Carcinoma, Non-Small-Cell Lung 28Breast Neoplasms 7Esophageal Neoplasms 5Ovarian Neoplasms 4Carcinoma, Renal Cell 4Stomach Neoplasms 3Small Cell Lung Carcinoma 3Salivary Gland Neoplasms 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Colorectal Neoplasms 3Colonic Neoplasms 3Brain Neoplasms 3Adenocarcinoma of Lung 3Urinary Bladder Neoplasms 2Tongue Neoplasms 2Thyroid Neoplasms 2Sarcoma 2Rectal Neoplasms 2Pleural Effusion, Malignant 2Pheochromocytoma 2Paraganglioma 2Oropharyngeal Neoplasms 2Neuroendocrine Tumors 2Nasopharyngeal Neoplasms 2Mouth Neoplasms 2Mesothelioma 2Melanoma 2Laryngeal Neoplasms 2

Interventions

pembrolizumab 92Nivolumab 57Cyclophosphamide 22Ipilimumab 17atezolizumab 15Magnetic Resonance Spectroscopy 14Specimen Handling 13Radiosurgery 13Paclitaxel 13Interleukin-2 12Docetaxel 12fludarabine 11Carboplatin 11Pemetrexed 10spartalizumab 9Biopsy 9durvalumab 8Cisplatin 8Radiotherapy 7Immune Checkpoint Inhibitors 7Blood Specimen Collection 7cemiplimab 6avelumab 6aldesleukin 6Taxes 6Gemcitabine 6Drug Therapy 6Bevacizumab 6trametinib 5tislelizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Melanoma × Fluorodeoxyglucose F18 × Thoracic × Clear all
NCT04119024 2026-03-17

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Stanford University

Phase 1 Recruiting
18 enrolled
BreastCNSDermatologicEndocrineHead & NeckNETThoracic

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Adenoma, Islet Cell, Melanoma, Neoplasm Metastasis, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms, Adrenocortical Carcinoma, Neuroendocrine Tumors

NCT01666353 2019-02-08

PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase EARLY_PHASE1 Completed
20 enrolled
DermatologicGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡